Seeing Is Believing
Currently, out of the existing stock ratings of Soumit Roy - 12 which are a Buy (85.71%), 1 which are a Hold (7.14%), 1 which are a Sell (7.14%)
Analyst Soumit Roy works at JONESTRADING and is covering the Healthcare sector with 25 price targets and ratings displayed on 6 stocks.
Soumit Roy's average stock forecast success ratio is 26.67% with an average time for price targets to be met of 55 days.
Most recent stock forecast was given on DCPH, Deciphera Pharmaceuticals at 06-Jan-2023.
Analyst best performing recommendations are on AVEO (AVEO PHARMACEUTICALS).
The best stock recommendation documented was for AVEO (AVEO PHARMACEUTICALS) at 3/14/2022. The price target of $12 was fulfilled within 218 days with a profit of $7.41 (161.44%) receiving and performance score of 7.41.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
20
$7.54 (60.51%)
18
1 months 17 days ago
2/5 (40%)
$12.76 (36.55%)
22
Buy
25
$12.54 (100.64%)
25
1 months 17 days ago
3/8 (37.5%)
$13.97 (72.54%)
118
Buy
23
$10.54 (84.59%)
23
3 months 22 days ago
1/5 (20%)
$6.76 (32.05%)
34
Buy
30
$17.54 (140.77%)
28
7 months 19 days ago
7/12 (58.33%)
$3 (13.99%)
199
Buy
30
$17.54 (140.77%)
25
8 months 2 days ago
0/2 (0%)
$10.69 (63.26%)
What Year was the first public recommendation made by Soumit Roy?